CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 130 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $412,800 | -18.9% | 15,000 | 0.0% | 0.23% | -17.0% |
| Q2 2023 | $508,950 | -5.7% | 15,000 | 0.0% | 0.28% | -24.2% |
| Q1 2023 | $539,700 | -19.3% | 15,000 | 0.0% | 0.37% | -43.7% |
| Q4 2022 | $668,550 | +39.9% | 15,000 | -11.8% | 0.66% | +34.6% |
| Q3 2022 | $478,000 | -27.2% | 17,000 | 0.0% | 0.49% | +157.1% |
| Q4 2021 | $657,000 | -28.4% | 17,000 | 0.0% | 0.19% | -18.0% |
| Q3 2021 | $918,000 | +9.8% | 17,000 | -32.0% | 0.23% | +2.6% |
| Q2 2021 | $836,000 | +62.3% | 25,000 | 0.0% | 0.23% | +30.5% |
| Q1 2021 | $515,000 | +744.3% | 25,000 | +614.3% | 0.17% | +596.0% |
| Q4 2020 | $61,000 | +17.3% | 3,500 | 0.0% | 0.02% | 0.0% |
| Q3 2020 | $52,000 | – | 3,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,605,390 | $71,552,232 | 10.98% |
| Octagon Capital Advisors LP | 761,398 | $33,935,509 | 5.28% |
| TSP Capital Management Group, LLC | 269,895 | $12,029,225 | 4.50% |
| Redmile Group, LLC | 1,977,451 | $88,134,991 | 3.60% |
| COMMODORE CAPITAL LP | 495,823 | $22,099 | 3.33% |
| Tri Locum Partners LP | 176,109 | $7,849,000 | 3.18% |
| ACUTA CAPITAL PARTNERS, LLC | 115,000 | $5,125,550 | 3.15% |
| Ikarian Capital, LLC | 267,476 | $11,921,406 | 2.88% |
| RTW INVESTMENTS, LP | 3,084,215 | $137,463,463 | 2.81% |
| Eversept Partners, LP | 558,774 | $24,904,557 | 2.18% |